Gail M. Gauvreau

9.8k citations

188 papers · 6.8k indexed · 3 hit papers · h-index 44

Physiology top 0.2%
Immunology top 0.5%
Pulmonary and Respiratory Medicine top 0.5%
Immunology and Allergy top 0.1%
Surgery top 2%

Co-authors: Paul M. O’Byrne Roma Sehmi Richard M. Watson Louis‐Philippe Boulet Donald W. Cockcroft Steven G. Smith Beth E. Davis Richard Leigh
Topics: Asthma and respiratory diseases (160 papers)Allergic Rhinitis and Sensitization (77 papers)Respiratory and Cough-Related Research (51 papers)
Cited by: Immunology and Allergy Physiology Immunology
Journals: New England Journal of MedicineSHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: Canada United States Australia

In The Last Decade

Gail M. Gauvreau

184 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

2014 587 citations Gail M. Gauvreau, Paul M. O’Byrne et al. profile →
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

2013 370 citations Gail M. Gauvreau, Richard Leigh et al. Journal of Allergy and Clinical Immunology profile →
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia

2015 363 citations Steven G. Smith, Paul M. O’Byrne et al. Journal of Allergy and Clinical Immunology profile →

Peers

Countries citing papers authored by Gail M. Gauvreau

Since Specialization

Citations

This map shows the geographic impact of Gail M. Gauvreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail M. Gauvreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail M. Gauvreau more than expected).

Fields of papers citing papers by Gail M. Gauvreau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail M. Gauvreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail M. Gauvreau. The network helps show where Gail M. Gauvreau may publish in the future.

Co-authorship network of co-authors of Gail M. Gauvreau

This figure shows the co-authorship network connecting the top 25 collaborators of Gail M. Gauvreau. A scholar is included among the top collaborators of Gail M. Gauvreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail M. Gauvreau. Gail M. Gauvreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Airway epithelial cells as drivers of severe asthma pathogenesis 2025 ·Mucosal Immunology ·Delbert R. Dorscheid,Gail M. Gauvreau,Steve N. Georas,Pieter S. Hiemstra,Gilda Varricchi,Bart N. Lambrecht,Gianni Marone	7
2	Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma 2025 ·Immunological Reviews ·(unknown),(unknown),Shazia Maqbool,(unknown),Gail M. Gauvreau	6
3	Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets 2024 ·Biomedicines ·(unknown),(unknown),(unknown),Gail M. Gauvreau	3
4	Multifactorial Causes and Consequences of TLSP Production, Function, and Release in the Asthmatic Airway 2024 ·Biomolecules ·(unknown),(unknown),(unknown),(unknown),Gail M. Gauvreau	7
5	Mannitol-evoked cough response is reduced by inhaled salbutamol 2024 ·ERJ Open Research ·(unknown),Ruth P. Cusack,(unknown),Karen Howie,(unknown),Kieran J. Killian,Paul M. O’Byrne,Imran Satia,Gail M. Gauvreau	0
6	Automated Cough Analysis with Convolutional Recurrent Neural Network 2024 ·Bioengineering ·Yiping Wang,(unknown),Tianqi Hong,(unknown),Gail M. Gauvreau,Ruth P. Cusack,Zhen Gao,Imran Satia,Qiyin Fang	0
7	Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma 2023 ·European Respiratory Journal ·Gail M. Gauvreau,Jens M. Hohlfeld,J. Mark FitzGerald,Louis‐Philippe Boulet,Donald W. Cockcroft,Beth E. Davis,Stephanie Korn,Oliver Kornmann,Richard Leigh,Irvin Mayers,Henrik Watz,Sarah Schmidt Grant,Monish Jain,Maciej Cabanski,Peter Pertel,Ieuan Jones,(unknown),Hui Cao,Paul M. O’Byrne	40
8	The Role of Airway Epithelial Cell Alarmins in Asthma 2022 ·Cells ·(unknown),(unknown),(unknown),Ruth P. Cusack,Gail M. Gauvreau	59
9	Allergen provocation tests in respiratory research: building on 50 years of experience 2022 ·European Respiratory Journal ·Gail M. Gauvreau,Beth E. Davis,Guy W. Scadding,Louis‐Philippe Boulet,Leif Bjermer,Adam Chaker,Donald W. Cockcroft,Barbro Dahlén,W.J. Fokkens,Peter W. Hellings,Nikolaos Lazarinis,Paul M. O’Byrne,Ellen Tufvesson,Santiago Quirce,(unknown),Frans H. de Jongh,Zuzana Diamant	19
10	Sounding the alarmins—The role of alarmin cytokines in asthma 2022 ·Allergy ·Gail M. Gauvreau,Céline Bergeron,Louis‐Philippe Boulet,Donald W. Cockcroft,Andréanne Côté,Beth E. Davis,Richard Leigh,(unknown),Paul M. O’Byrne,Roma Sehmi	63
11	Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment 2021 ·Cells ·Ruth P. Cusack,(unknown),Yanqing Xie,(unknown),Gail M. Gauvreau	19
12	Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction 2020 ·European Respiratory Journal ·Christopher D. Pascoe,Aruni Jha,Min Hyung Ryu,(unknown),(unknown),Sujata Basu,Gerald L. Stelmack,Sadeesh Srinathan,Biniam Kidane,Jason Kindrachuk,Paul M. O’Byrne,Gail M. Gauvreau,Amir Ravandi,Christopher Carlsten,Andrew J. Halayko	17
13	Type 2 innate lymphoid cells expressing death receptor 3 are increased in airway of mild atopic asthmatic subject following allergen inhalation challenge 2018 ·Journal of Allergy and Clinical Immunology ·Kentaro Machida,Adrian J. Baatjes,Richard M. Watson,(unknown),Gail M. Gauvreau,Paul M. O’Byrne,Roma Sehmi	2
14	Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response 2017 ·American Journal of Respiratory and Critical Care Medicine ·Amrit Singh,Casey P. Shannon,(unknown),Chen Xi Yang,Robert Balshaw,Gabriela V. Cohen Freue,Gail M. Gauvreau,J. Mark FitzGerald,Louis‐Philippe Boulet,Paul M. O’Byrne,Scott J. Tebbutt	16
15	Interleukin 25 Receptor Expression on Airway Dendritic Cells After Allergen Challenge in Asthmatic Subjects. 2015 ·American Journal of Respiratory and Critical Care Medicine ·Damian Tworek,Steven G. Smith,Brittany Salter,Adrian J. Baatjes,(unknown),Rick Watson,(unknown),Gail M. Gauvreau,Paul M. O’Byrne	2
16	Single-dose desloratadine and montelukast and allergen-induced late airway responses 2009 ·European Respiratory Journal ·Beth E. Davis,(unknown),Gail M. Gauvreau,Richard M. Watson,Paul M. O’Byrne,Francine Deschesnes,LP Boulet,Donald W. Cockcroft	36
17	Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma 2009 ·Respiratory Medicine ·Louis‐Philippe Boulet,Catherine Lemière,Gail M. Gauvreau,Ron Olivenstein,(unknown),(unknown),Paul M. O’Byrne,(unknown),Paolo Renzi	6
18	The Effect of Pranlukast on Allergen-induced Bone Marrow Eosinophilopoiesis in Subjects with Asthma 2004 ·American Journal of Respiratory and Critical Care Medicine ·Krishnan Parameswaran,Richard M. Watson,Gail M. Gauvreau,Roma Sehmi,Paul M. O’Byrne	40
19	Kinetics of Bone Marrow Eosinophilopoiesis and Associated Cytokines after Allergen Inhalation 2003 ·American Journal of Respiratory and Critical Care Medicine ·Sandra C. Dorman,Roma Sehmi,Gail M. Gauvreau,Rick Watson,Ronan Foley,Graham L. Jones,Judah A. Denburg,Mark D. Inman,Paul M. O’Byrne	69
20	Effects of Inhaled Budesonide on Allergen-Induced Airway Responses and Airway Inflammation 1996 ·American Journal of Respiratory and Critical Care Medicine ·Gail M. Gauvreau,(unknown),Richard M. Watson,Manel Jordana,Paul M. O’Byrne	128

About Gail M. Gauvreau

Gail M. Gauvreau is a scholar working on Immunology and Allergy, Physiology and Immunology, having authored 188 papers that have together received 6.8k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (160 papers), Allergic Rhinitis and Sensitization (77 papers) and Respiratory and Cough-Related Research (51 papers). The work is most often cited by research in Immunology and Allergy (2.0k citations), Physiology (5.1k citations) and Immunology (2.6k citations). Gail M. Gauvreau has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Paul M. O’Byrne, Roma Sehmi, Richard M. Watson, Louis‐Philippe Boulet, Donald W. Cockcroft, Steven G. Smith, Beth E. Davis, Richard Leigh, John Paul Oliveria and Judah A. Denburg. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact